The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
- PMID: 27035814
- PMCID: PMC4811160
- DOI: 10.1172/JCI87345
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Retraction of
-
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.J Clin Invest. 2005 Apr;115(4):1068-81. doi: 10.1172/JCI22758. Epub 2005 Mar 10. J Clin Invest. 2005. Retraction in: J Clin Invest. 2016 Apr 1;126(4):1603. doi: 10.1172/JCI87345. PMID: 15761501 Free PMC article. Retracted.
References
-
- Melillo RM, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol. 2004;165(2):511–521. doi: 10.1016/S0002-9440(10)63316-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials